Astec LifeSciences Limited has informed the Exchange regarding a press release dated April 27, 2026, titled "PRESS RELEASE".

Revenue Growth 20pctPat NegativeEbitda Margin ExpansionExceptional ItemResults View source PDF Explain this filing

ASTEC · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-2.7%Reaction day

₹748.80

prior close

₹758.00

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-0.2%-2.5% vs market

Pesticides & Agrochemicals peers, median of 27sector-0.5%-2.2% vs sector

On the reaction day the stock moved 2.5 pts less than Nifty Microcap 250 and 2.2 pts less than its Pesticides & Agrochemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-2.6

10m

-3.2

15m

-3.5

30m

-3.4

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-2.7-0.2-2.5-0.5-2.2

Next day

-7.1-0.2-6.9-0.2-6.9

-7.2-0.5-6.7-0.1-7.1

-3.8+0.9-4.8+0.4-4.2

-8.7+0.9-9.5+0.8-9.4

-6.5+2.5-9.0+2.8-9.3

-5.2+4.0-9.2+1.9-7.1

15d

-0.5-0.4-0.1-2.4+1.8

+2.4+2.4-0.0-4.9+7.4

-4.6+7.8-12.5-5.6+1.0

-13.7+8.0-21.8-6.4-7.3

UpDownMarket · Nifty Microcap 250Sector · Pesticides & Agrochemicals peers, median of 27Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Astec LifeSciences reported strong Q4 FY26 revenue growth of 34% year-on-year, with total income rising to ₹161.3 crore from ₹120.3 crore. The company achieved significant turnaround in EBITDA to ₹11.8 crore in Q4 FY26 from ₹6.3 crore in Q4 FY25, an 87% improvement. For the full year FY26, total income grew 17.1% to ₹453.2 crore from ₹386.9 crore, with EBITDA improving from a loss of ₹60.6 crore to breakeven at ₹0.5 crore. Despite these improvements, the company continues to report losses after tax - ₹7.7 crore in Q4 and ₹80.9 crore for FY26 (though improved from losses of ₹16.1 crore and ₹134.7 crore respectively in the prior year). The company also classified ₹2.1 crore as exceptional items related to new labour code regulations.

Likely market impact

The company shows encouraging signs of operational recovery with strong revenue growth and margin expansion, though shareholders should note that losses persist and full-year EBITDA remains barely breakeven.